miR-150-PTPMT1-cardiolipin signaling in pulmonary arterial hypertension

Autor: Russomanno, Giusy, Jo, Kyeong Beom, Abdul-Salam, Vahitha B., Morgan, Claire, Endruschat, Jens, Schaeper, Ute, Osman, Ahmed H., Alzaydi, Mai M., Wilkins, Martin R., Wojciak-Stothard, Beata

Publikováno v: In Molecular Therapy - Nucleic Acids 5 March 2021 23:142-153

Author Correction:Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension (Nature Communications, (2020), 11, 1, (1185), 10.1038/s41467-020-14966-x)

Autor: Sindi, Hebah A., Russomanno, Giusy, Satta, Sandro, Abdul-Salam, Vahitha B., Jo, Kyeong Beom, Qazi-Chaudhry, Basma, Ainscough, Alexander J., Szulcek, Robert, Bogaard, Harm Jan, Morgan, Claire C., Pullamsetti, Soni S., Alzaydi, Mai M., Rhodes, Christopher J., Piva, Roberto, Eichstaedt, Christina A., Grünig, Ekkehard, Wilkins, Martin R., Wojciak-Stothard, Beata

Publikováno v: Sindi, H A, Russomanno, G, Satta, S, Abdul-Salam, V B, Jo, K B, Qazi-Chaudhry, B, Ainscough, A J, Szulcek, R, Bogaard, H J, Morgan, C C, Pullamsetti, S S, Alzaydi, M M, Rhodes, C J, Piva, R, Eichstaedt, C A, Grünig, E, Wilkins, M R & Wojciak-Stothard, B 2020, ' Author Correction : Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension (Nature Communications, (2020), 11, 1, (1185), 10.1038/s41467-020-14966-x) ', Nature Communications, vol. 11, no. 1, 3300 . https://doi.org/10.1038/s41467-020-17273-7

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10172::b736c86d3be2d2097e76230d7a7d70c4
https://research.vumc.nl/en/publications/bf94981d-5cb7-438c-8c62-c4b643666a01

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

miR-150-PTPMT1-cardiolipin signaling in pulmonary arterial hypertension.

Autor: Russomanno G; National Heart and Lung Institute, Imperial College London, London, UK.; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology (ISMIB), University of Liverpool, Liverpool, UK., Jo KB; National Heart and Lung Institute, Imperial College London, London, UK., Abdul-Salam VB; National Heart and Lung Institute, Imperial College London, London, UK.; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Morgan C; National Heart and Lung Institute, Imperial College London, London, UK., Endruschat J; Silence Therapeutics GmbH, Berlin, Germany., Schaeper U; Silence Therapeutics GmbH, Berlin, Germany., Osman AH; National Heart and Lung Institute, Imperial College London, London, UK., Alzaydi MM; National Heart and Lung Institute, Imperial College London, London, UK.; National Center for Biotechnology, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia., Wilkins MR; National Heart and Lung Institute, Imperial College London, London, UK., Wojciak-Stothard B; National Heart and Lung Institute, Imperial College London, London, UK.

Publikováno v: Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2020 Nov 04; Vol. 23, pp. 142-153. Date of Electronic Publication: 2020 Nov 04 (Print Publication: 2021).